Spectral AI, Inc. 8-K

What Happened

• Spectral AI, Inc. announced (in an 8‑K filed July 8, 2026) that the Board has appointed Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Mrs. Bajko joins from MediView XR, where she led commercialization and customer success and helped launch three FDA‑cleared augmented‑reality imaging platforms, growing revenue from pre‑commercial to more than $2.2 million. Her offer letter is dated July 7, 2026.

Key Details

• Base salary: $315,000 per year.
• Bonus: Eligible for an annual target bonus up to 30% of base pay, tied to Board‑defined milestones and goals.
• Equity: Grant of stock options to acquire 150,000 common shares under the Company’s 2023 Long Term Incentive Plan; options vest annually over three years (first vesting on the first anniversary) and fully vest upon a change of control.
• Effective date of employment: July 31, 2026.

Why It Matters

• The hire strengthens Spectral AI’s commercial leadership as the company seeks to commercialize its imaging/AI products; Bajko’s prior experience launching FDA‑cleared platforms and building go‑to‑market teams is directly relevant to driving product adoption and revenue growth.
• Compensation is a mix of cash and equity, aligning Bajko’s incentives with company performance and potential exit events (change‑of‑control acceleration). Investors should note the 150,000‑share option grant as potential future dilution as those options vest and, if exercised, convert to outstanding shares.